Cell transplantation for myocardial regeneration: Hype or reality?

Scandinavian Cardiovascular Journal

Volumn 38, Issue 5, 2004, Pages 259-264

  Björquist, Petter ^a   Jeppsson, Anders ^b  

^a Cellartis AB   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

BONE MARROW CELL; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CELL SUBPOPULATION; CELL TRANSPLANTATION; CLINICAL STUDY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; DNA MODIFICATION; EMBRYO CELL; EXPERIMENTATION; GENE THERAPY; HEART ASSIST DEVICE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HOST; HUMAN; ISCHEMIC HEART DISEASE; METHODOLOGY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PARKINSON DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZATION; RECIPIENT; REVIEW; STATISTICAL ANALYSIS; STEM CELL;

BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 7744233810     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430410016350     Document Type: Review

References (71)

1. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002; 4(3): 361-371.
2. Stewart S, MacIntyre K, Capewell S, McMurray JJ. Heart failure and the aging population: An increasing burden in the 21st century? Heart 2003; 89(1): 49-53.
3. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998; 95(15): 8801-8805.
4. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344(23): 1750-1757.
5. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003; 100(21): 12313-12318.
6. Hagege AA, Carrion C, Menasché P, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003; 361(9356): 491-492.
7. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003; 107(21): 2733-2740.
8. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103(5): 697-705.
9. Al Attar N, Carrion C, Ghostine S, et al. Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc Res 2003; 58(1): 142-148.
10. Min JY, Yang Y, Converso KL, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002; 92(1): 288-296.
11. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100(19 Suppl): II247-II256.
12. Menasché P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41(7): 1078-1083.
13. Perin EC, Dohmann HE, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107(18): 2294-2302.
14. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361(9351): 45-46.
15. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106(15): 1913-1918.
16. Assmus B, Schachinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCAREAMI). Circulation 2002; 106(24): 3009-3017.
17. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361(9351): 47-49.
18. Smits PC, van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Cardiol 2003; 42(12): 2063-2069.
19. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003; 41(5): 879-888.
20. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961; 9: 493-495.
21. Menasché P. Myoblast-based cell transplantation. Heart Fail Rev 2003; 8(3): 221-227.
22. Zibaitis A, Greentree D, Ma F, Marelli D, Duong M, Chiu RC. Myocardial regeneration with satellite cell implantation. Transplant Proc 1994; 26(6): 3294.
23. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 1998; 4(8): 929-933.
24. Ghostine S, Carrion C, Souza LC, et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002; 106(12 Suppl 1): I131-I136.
25. Tambara K, Sakakibara Y, Sakaguchi G, et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 2003; 108 Suppl 1: II259-II263.
26. Pouzet B, Vilquin JT, Hagege AA, et al Intramyocardial transplantation of autologous myoblasts: Can tissue processing be optimized? Circulation 2000; 102(19 Suppl 3): III210-III215.
27. Taylor DA, Silvestry SC, Bishop SP, et al. Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: A potential approach to myocardial repair. Proc Assoc Am Physicians 1997; 109(3): 245-253.
28. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: Myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995; 60(1): 12-18.
29. Dorfman J, Duong M, Zibaitis A, et al. Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg 1998; 116(5): 744-751.
30. Leobon B, Garcin I, Menasché P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003; 100(13): 7808-7811.
31. Pouzet B, Vilquin JT, Hagege AA, et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 2001; 71(3): 844-850; discussion 850-851.
32. Menasché P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357(9252): 279-280.
33. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9(5): 641-650.
34. McKay R. Stem cells in the central nervous system. Science 1997; 276(5309): 66-71.
35. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284(5417): 1168-1170.
36. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418(6893): 41-49.
37. Bittner RE, Schofer C, Weipoltshammer K, et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 1999; 199(5): 391-396.
38. Agbulut O, Menot ML, Li Z, et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 2003; 58(2): 451-459.
39. Davani S, Marandin A, Mersin N, et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003; 108 Suppl 1: II253-II258.
40. Orlic D, Kajstura, J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann NY Acad Sci 2001; 938: 221-229; discussion 229-230.
41. Orlic D. Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann NY Acad Sci 2003; 996: 152-157.
42. Saito T, Kuang JQ, Lin CC, Chiu RC. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg 2003; 126(1): 114-123.
43. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7(4): 430-436.
44. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107(11): 1395-1402.
45. Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002; 123(6): 1132-1140.
46. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 2000; 120(5): 999-1005.
47. Wang JS, Shum-Tim D, Chedrawy E, Chiu RC. The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 2001; 122(4): 699-705.
48. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98(18): 10344-10349.
49. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428(6983): 664-668.
50. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428(6983): 668-673.
51. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10(5): 494-501.
52. Tang YL, Zhao Q, Zhang YC, et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 2004; 117(1): 3-10.
53. Norol F, Merlet P, Isnard R, et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 2003; 102(13): 4361-4368.
54. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004; 363(9411): 751-756.
55. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363(9411): 783-784.
56. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292(5819): 154-156.
57. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000; 18(4): 399-404.
58. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-1147.
59. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J. Stem cells. Setting standards for human embryonic stem cells. Science 2003; 300(5621): 913-916.
60. Min JY, Yang Y, Sullivan MF, et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003; 125(2): 361-369.
61. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108(3): 407-414.
62. Heng BC, Haider H, Sim EK, Cao T, Ng SC. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res 2004; 62(1): 34-42.
63. Johkura K, Cui L, Suzuki A, et al. Survival and function of mouse embryonic stem cell-derived cardiomyocytes in ectopic transplants. Cardiovasc Res 2003; 58(2): 435-443.
64. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99(15): 9864-9869.
65. Carpenter MK, Resler ES, Fisk GJ, et al. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn 2004; 229(2): 243-258.
66. Hwang WS, Ryu YJ, Park JH, et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 2004; 303(5664): 1669-1674.
67. Amit M, Shariki C, Margulets V, Itskovitz-Eldor J. Feeder layer- and serumfree culture of human embryonic stem cells. Biol Refired 2004; 70(3): 837-845.
68. Yau TM, Tomita S, Weisel RD, et al. Beneficial effect of autologous cell transplantation on infarcted heart function: Comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg 2003; 75(1): 169-176; discussion 176-177.
69. Scorsin M, Hagege A, Vilquin JT, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2000; 119(6): 1169-1175.
70. Thompson RB, Emani SM, Davis BH, et al. Comparison of intracardiac cell transplantation: Autologous skeletal myoblasts versus bone marrow cells. Circulation 2003; 108 Suppl 1: II264-II271.
71. Park S, Kim EY, Ghil GS, et al. Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. Neurosci Lett 2003; 353(2): 91-94.